-
Loading metrics
Targeting caveolae to pump bispecific antibody to TGF-β into diseased lungs enables ultra-low dose therapeutic efficacy
- Anil H. Kadam,
- Kathirvel Kandasamy,
- Tim Buss,
- Brittany Cederstrom,
- Chun Yang,
- Sreekanth Narayanapillai,
- Juan Rodriguez,
- Michael D. Levin,
- Jim Koziol,
- Bogdan Olenyuk
x
- Published: November 22, 2022
- https://doi.org/10.1371/journal.pone.0276462